4 Surging Diagnostics & Research Stocks to Buy in September By StockNews

0
26
© Reuters. 4 Surging Diagnostics & Research Stocks to Buy in September

While the COVID-19 pandemic highlighted the importance of the diagnostics and research industry, the sector is expected to continue growing due to the rise in chronic diseases and AI-based innovations. So, we think it could be wise to scoop up the shares of quality diagnostics and research stocks Agilent (A), Mettler-Toledo (NYSE:), Laboratory Corporation of America (NYSE:), and Waters Corporation (NYSE:). Let’s discuss.The resurgence of COVID-19 cases across several parts of the world has been driving the diagnosis and research industry’s growth. Furthermore, according to the CDC, six in 10 Americans live with at least one chronic disease, such as heart disease, stroke, cancer, or diabetes. So, rising chronic disorders are expected to boost the industry’s prospects.

Also, the application of artificial intelligence (AI) in the industry is expected to drive further growth. According to a Grand View Research report, the use of AI in the diagnostics market is expected to grow at a 32.8% CAGR over the next seven years.

Given this backdrop, we think it could be wise to bet on fundamentally strong diagnostics and research stocks Agilent Technologies, Inc. (NYSE:), Mettler-Toledo International Inc . (MTD), Laboratory Corporation of America Holdings (LH), and Waters Corporation (WAT).

Continue reading on StockNews

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.